Manufacturer of Controlled Substances; Notice of Application

---
identifier: "/us/fr/03-17123"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances; Notice of Application"
title_number: 0
title_name: "Federal Register"
section_number: "03-17123"
section_name: "Manufacturer of Controlled Substances; Notice of Application"
positive_law: false
currency: "2003-07-08"
last_updated: "2003-07-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "03-17123"
document_type: "notice"
publication_date: "2003-07-08"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "68 FR 40686"
fr_volume: 68
---


#  Manufacturer of Controlled Substances; Notice of Application

Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 8, 2003, Cody Laboratories, Inc., made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Diphenoxylate (9170)—Schedule II

Meperidine (9230)—Schedule II

Oxymorphone (9652)—Schedule II

Sufentanil (9740)—Schedule II

The firm plans to manufacture bulk material for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, *Attention:* DEA Federal Register Representative (CCD) and must be filed no later than September 8, 2003.

Laura M. Nagel,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.